Cargando…
Rethinking the Doses of Tissue Plasminogen Activator and Deoxyribonuclease Administrated Concurrently for Intrapleural Therapy for Complicated Pleural Effusion and Empyema
Background Complicated parapneumonic effusions empyema (CPEE) is fairly common and associated with increased morbidity and mortality. The Multicenter Intrapleural Sepsis Trial 2 (MIST 2) established the combination of intrapleural deoxyribonuclease (DNase) and tissue plasminogen activator (tPA) as a...
Autores principales: | Innabi, Ayoub, Surana, Alok, Alzghoul, Bashar, Meena, Nikhil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368361/ https://www.ncbi.nlm.nih.gov/pubmed/30755840 http://dx.doi.org/10.7759/cureus.2214 |
Ejemplares similares
-
Effects of Concurrent Dosing on the Efficacy of Tissue Plasminogen Activator and Deoxyribonuclease in the Treatment of Pleural Infection
por: Pathak, Vikas, et al.
Publicado: (2023) -
Successful management of pleural infection with very low dose intrapleural tissue plasminogen activator/deoxyribonuclease regime
por: Hart, Jodi Andrea, et al.
Publicado: (2019) -
New therapy of pleural empyema by deoxyribonuclease
por: Kacprzak, Grzegorz, et al.
Publicado: (2013) -
Rare Presentation of a Posterior Mediastinal Cystic Schwannoma as a Large Pleural Effusion
por: Mubashir, Mujtaba, et al.
Publicado: (2017) -
Bilateral Myelomatous Pleural Effusion in a Patient with IgA Kappa Multiple Myeloma
por: Asiamah, Rebecca, et al.
Publicado: (2017)